Evidence map›Paper›PMID 25912617›Full record

ReviewInfluenza and other respiratory viruses2015

Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance.

Qiu Sue Huang, Nikki Turner, Michael G Baker, Deborah A Williamson, Conroy Wong, Richard Webby, Marc-Alain Widdowson

Abstract readReview
In one paragraph

Review in Influenza and other respiratory viruses, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qiu Sue HuangInstitute of Environmental Science and Research, Wellington, New Zealand.
Nikki TurnerUniversity of Auckland, Auckland, New Zealand.
Michael G BakerUniversity of Otago, Wellington, New Zealand.
Deborah A WilliamsonInstitute of Environmental Science and Research, Wellington, New Zealand.
Conroy WongCounties Manakau District Health Board, Auckland, New Zealand.
Richard WebbyWHO Collaborating Centre, St Jude Children's Research Hospital, Memphis, TN, USA.
Marc-Alain WiddowsonCenters for Disease Control and Prevention (CDC), Atlanta, GA, USA.

Funding

Southern Hemisphere Influenza and Vaccine Effectiveness Research and SurveillanceU01IP000480 · IP · INST OF ENVIRONMENTAL SCIENCE & RESEARCH · PI HUANG, SUE · 2011 to 2015
$7.0M
NCIRD CDC HHS 1U01IP000480-01NCIRD CDC HHS U01 IP000480
6 · The paper itself

Abstract

The 2009 influenza A(H1N1)pdm09 pandemic highlighted the need for improved scientific knowledge to support better pandemic preparedness and seasonal influenza control. The Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance (SHIVERS) project, a 5-year (2012-2016) multiagency and multidisciplinary collaboration, aimed to measure disease burden, epidemiology, aetiology, risk factors, immunology, effectiveness of vaccination and other prevention strategies for influenza and other respiratory infectious diseases of public health importance. Two active, prospective, population-based surveillance systems were established for monitoring influenza and other respiratory pathogens among those hospitalized patients with acute respiratory illness and those enrolled patients seeking consultations at sentinel general practices. In 2015, a sero-epidemiological study will use a sample of patients from the same practices. These data will provide a full picture of the disease burden and risk factors from asymptomatic infections to severe hospitalized disease and deaths and related economic burden. The results during the first 2 years (2012-2013) provided scientific evidence to (a) support a change to NZ's vaccination policy for young children due to high influenza hospitalizations in these children; (b) contribute to the revision of the World Health Organization's case definition for severe acute respiratory illness for global influenza surveillance; and (c) contribute in part to vaccine strain selection using vaccine effectiveness assessment in the prevention of influenza-related consultations and hospitalizations. In summary, SHIVERS provides valuable international platforms for supporting seasonal influenza control and pandemic preparedness, and responding to other emerging/endemic respiratory-related infections.

Indexed as

Biomedical ResearchHumansInfluenza A virusInfluenza, HumanInfluenza VaccinesPopulation SurveillanceInfluenza Vaccinesdisease burdenepidemiologyimmunologyinfluenzarisk factorsvaccine effectiveness

Identifiers

PMID25912617
PMCPMC4474494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.